- $84.72m
- $627.52m
- $1.25bn
Brief: Innovate Agrees To $650 Million Sale Of Dbm Global To IES Holdings
INNOVATE swings to Q2 profit on higher gross profit and debt extinguishment gains
Brief: INNOVATE Corp. Q2 Revenue USD 421.6 Million
INNOVATE Q1 revenue rises 33%, net loss narrows
Brief: INNOVATE Corp. Q1 Revenue USD 364.8 Million
Brief: Medibeacon® Transdermal Gfr Monitor And Reusable Sensor Receive CE Mark Under European Medical Device Regulation
INNOVATE Q4 revenue jumps 61.7%, net loss narrows
Brief: INNOVATE Corp. Q4 Revenue USD 382.7 Million
Brief: Medibeacon® Next Generation Tgfr™ System Receives FDA Approval
INNOVATE Q3 revenue jumps on infrastructure segment growth
Brief: INNOVATE Corp. Q3 Revenue USD 347.1 Million
Brief: MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
Brief: INNOVATE Corp. Q2 Revenue USD 242 Million
Brief: Innovate Announces Early Results Of Exchange Offer Of Senior Secured Notes And Solicitation Of Consents And Extends Availability Of Total Early Exchange Consideration
Brief: INNOVATE Corp. Q1 Net Income USD -24.8 Million
Brief: Innovate Corp Q4 Consolidated Revenue $236.6 Million
Brief: Innovate Regains Compliance With NYSE Minimum Price Requirement
Brief: INNOVATE Corp. Q2 Net Income USD 14.1 Million
Brief: INNOVATE Corp. Q1 Net Income USD -17.7 Million